Roles of degree of fat deposition and its localization on VEGF expression in adipocytes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Miyazawa Hoshimoto, Saori ^a   Takahashi, Kazuo ^a   Bujo, Hideaki ^a   Hashimoto, Naotake ^a   Yagui, Kazuo ^a   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

3T3 L1 cells; Cytokine; Fat distribution; Gene expression; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL STRAIN 3T3; CONTROLLED STUDY; GROWTH; LIPID STORAGE; MOUSE; NONHUMAN; NUDE MOUSE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, OBESE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 19444365254     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00003.2004     Document Type: Article

References (22)

1. Afuwape AO, Kiriakidis S, and Paleolog EM. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 17: 961-972, 2002.
2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, and King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994.
3. Chiarelli F, Spagnolit A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G, and Verrotti A. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Med 17: 650-656, 2000.
4. Claffey KP, Wilkison WO, and Spiegelman BM. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267: 16317-16322, 1992.
5. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
6. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 6: 10-14, 2002.
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, and Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
8. Kubota Y, Kleinman HK, Martin GR, and Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107: 1589-1598, 1988.
9. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
10. MacDougald OA, Hwang CS, Fan H, and Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 92: 9034-9037, 1995.
11. Madrup S, Loftus TM, MacDougald OA, Kuhajda FP, and Lane MD. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci USA 94: 4300-4305, 1997.
12. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, and Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 190: 227-235, 1997.
13. Matsumoto F, Bujo H, Kuramochi D, Saito K, Shibasaki M, Takahashi K, Yoshimoto S, Ichinose M, and Saito Y. Effects of nutrition on the cell survival and gene expression of transplanted fat tissues in mice. Biochem Biophys Res Commun 295: 630-635, 2002.
14. Mertens I, Van der Planken M, Corthouts B, Wauters M, Peiffer F, De Leeuw I, and Van Gaal L. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women. Horm Metab Res 33: 602-607, 2001.
15. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, and Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46: 1483-1488, 2003.
16. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 4: S81-S90, 2002.
17. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, and Ginsburg GS. Atherosclerosis: a cancer of the blood vessels? Am J Clin Pathol 116: S97-S107, 2001.
18. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, and Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324, 1993.
19. Shibasaki M, Takahashi K, Itou T, Miyazawa S, Ito M, Kobayashi J, Bujo H, and Saito Y. Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 45: 518-526, 2002.
20. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, and Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2: 800-803, 1996.
21. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, and Katsilambros N. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48: 1332-1335, 1999.
22. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, and Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9: 414-417, 2001.